We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product cand... SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body's normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Show more
Ask ADVFN Intelligence (AI)
SANUWAVE is pleased to announce preliminary revenues of $10.1 million to $10.3 million for the fourth quarter ended December 31, 2024. This represents the highest quarterly revenues in...
Wern Brings Strong Team Building, Growth, and Sales Skills to SANUWAVE After a Career of Growing Start Ups Into Mid and Large Sized Companies EDEN PRAIRIE, MN -- January 13, 2025...
Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023 GAAP Operating...
1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion...
Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024EDEN PRAIRIE, MN -- October 16, 2024 -- InvestorsHub NewsWire -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE...
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income was $2.0...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.25 | -0.909090909091 | 27.5 | 28 | 26.37 | 4286 | 27.54245777 | CS |
| 4 | 1.45 | 5.62015503876 | 25.8 | 29.1925 | 24.5 | 7854 | 27.48157886 | CS |
| 12 | 3.75 | 15.9574468085 | 23.5 | 29.1925 | 18.502 | 9739 | 23.68577402 | CS |
| 26 | 21.625 | 384.444444444 | 5.625 | 29.1925 | 5.2125 | 339950 | 9.46663409 | CS |
| 52 | 18.625 | 215.942028986 | 8.625 | 29.1925 | 4.275 | 341777 | 8.42506843 | CS |
| 156 | -29 | -51.5555555556 | 56.25 | 69.375 | 0.525 | 351537 | 10.77703567 | CS |
| 260 | -47.75 | -63.6666666667 | 75 | 119.625 | 0.0375 | 338442 | 35.37948587 | CS |
op1
6 seconds ago
BigBadWolf
13 seconds ago
Trooperstocks
19 seconds ago
Mark
31 seconds ago
surfkast
38 seconds ago
Doc logic
49 seconds ago
bri123
51 seconds ago
RIGATONI
52 seconds ago
toohot
1 minute ago
RIGATONI
1 minute ago
Trooperstocks
1 minute ago
Trooperstocks
1 minute ago
toohot
2 minutes ago
dinogreeves
2 minutes ago
Vexari
2 minutes ago
toohot
2 minutes ago
surfkast
2 minutes ago
dexprs
2 minutes ago
Trooperstocks
2 minutes ago
Trooperstocks
3 minutes ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
